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Abstract 
Introduction: Formamidines pesticides have been described to induce permanent effects on development of monoaminergic 
neurotransmitters systems. The mechanisms that induce these effects are not known but it has been suggested that these effects 
could be related to monoamino oxidase (MAO) inhibition. Chlordimeform is a formamidine pesticide which is a very weak inhibitor 
of MAO although it has been also described to produce neurodevelopmental toxicity. 
Objectives and methods: The effects of maternal exposure to chlordimeform on brain region serotonin levels of male and female 
offspring rats at 60 days of age were evaluated. Maternal and offspring body weight, physical and general activity development 
were unaffected by the exposure of dams to chlordimeform (5 mg/kg bw, orally on days 6–21 of pregnancy and 1–10 of lactation). 
Male and female offspring were sacrificed at 60 days of age and possible alterations in the content and metabolism of 5-HT was 
determined in brain regions by HPLC. 
Results: The results showed that this neurotransmitter system was altered in a brain regional-related manner. In male and female 
offspring, chlordimeform induced a significant decrease in the striatum and prefrontal cortex 5-HT and its metabolite 5-HIAA levels. 
This effect was with statistical distinction of sex in the prefrontal cortex. In contrast, chlordimeform caused an increase in 5-HT and 
5-HIAA content in the hippocampus in male and female offspring with sex interaction. Chlordimeform evoked increases in 5-HT 
turnover in the prefrontal cortex and hippocampus from females and males respectively but evoked a decrease in these regions 
from males and females respectively. 
Conclusions: The present findings indicated that maternal exposure to chlordimeform altered serotonergic neurochemistry in their 
offspring in prefrontal cortex, striatum and hippocampus, and those variations show that other mechanisms different from MAO 
inhibition are implicated.
Keywords: Formamidines; neurodevelopmental toxicity; chlordimeform; rats; serotonin; human risk assessment
Resumen
Introducción: Se ha descrito que los pesticidas formamidinicos inducen efectos permanentes en el desarrollo de los sistemas de 
neurotransmisores monoaminérgicos. Los mecanismos por los que se inducen estos efectos no se conocen, pero se ha sugerido 
que podrían estar relacionados con la inhibición de la monoamino oxidasa (MAO). El clordimeformo, es un pesticida formamidinico, 
del que se han descrito efectos neurotoxicos en el desarrollo, aunque es un inhibidor muy débil de la MAO. 
Objetivos y métodos: En el presente estudio se evaluaron los efectos sobre los niveles de serotonina en regiones cerebrales de 
ratas macho y hembra a los 60 días de edad tras la exposición maternal al clodimeformo (5 mg/kg de peso corporal, por vía oral 
en los días 6-21 de la gestación y 1-10 de la lactancia). El peso corporal de las madres y las crías, y el desarrollo físico y de la 
actividad general no se vieron afectados por la exposición al clordimeformo. Las crías fueron sacrificadas a los 60 días de edad y 
las posibles alteraciones en el contenido y metabolismo de 5-HT se determinaron en regiones cerebrales mediante HPLC. 
Resultados: El clordimeformo indujo una disminución significativa en el cuerpo estriado y la corteza prefrontal de los niveles de 
5-HT y su metabolito 5-HIAA. Este efecto fue estadísticamente influenciado por el sexo en la corteza prefrontal. Por el contrario, el 
clordimeformo causó un aumento del contenido de la 5-HT y de 5-HIAA en el hipocampo con influencia significativa por sexo. El 
clordimeformo provoco aumentos en la tasa de recambio de 5-HT en la corteza prefrontal y el hipocampo de hembras y machos 
respectivamente, sin embargo, provocó una disminución en estas regiones en machos y hembras respectivamente. 
Conclusiones: Los presentes resultados indican que las formamidinas y en particular el clordimeformo inducen tras la exposición 
maternal una alteración permanente del sistema serotoninérgico de forma región y sexo dependiente en la descendencia, las 
cuales muy probablemente se deban a mecanismos distintos de la inhibición de la MAO.
Palabras clave: Formamidinas; neurotoxicidad en el desarrollo; clodimeformo; ratas; serotonina; evaluación del riesgo para el hombre
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Introduction 
Chlodimeform [N2-(4-chloro-o-tolyl)-N1. N1-dimethylfor-
mamidine] (Figure 1) is a member of the formamidine 
pesticides, widely used as a broad spectrum acaricide, 
and in agriculture for the protection of fruits, and vegeta-
bles1. Monoamine oxidase (MAO) inhibition was among 
the first biochemical actions of the formamidines that were 
reported2-3. Thus, aminergic mechanism of action of chlor-
dimeform was quickly postulated and adopted because 
neuronal MAO participates in metabolic inactivation of 
biogenic monoamines which include the neurotransmit-
ters serotonin, norepinephrine, and dopamine. In addition, 
chlordimeform is an antagonist of reserpine effects4, alters 
prostaglandin synthesis5, has α2 receptor agonist proper-
ties6, and is an endocrine disruptor7. 
Pesticides pose a growing risk to health, with a specific 
concern about the possible permanent effects that these 
compounds may have on the development of organisms. 
Thus, it has been described for formamidine compound 
amitraz, the induction of permanent alterations on the 
development of central nervous system (CNS) such as 
those that affect monoamine neurotransmitter systems, 
although there is not information about neurodevelop-
mental effects of other formamidine compounds. The 
mechanism by which these effects occur is not known 
but currently it is assumed that the monoaminergic neu-
rotransmitters play a role during development, defined as 
“morphogenetic”8-11. Any change in the levels of catecho-
lamines during development could have a profound effect 
on brain development, both structural and functional12. 
In this sense, it has been suggested as a possible me-
chanism of action the inhibition of MAO which may alter 
the levels of monoaminergic neurotransmitters, although 
other mechanisms as endocrine disruption on sex hor-
mones that control the expression of enzymes that ca-
talyze the synthesis and metabolism of the monoamine 
neurotransmitters cannot be excluded13. 
According to all exposed above, we performed a study 
to establish if maternal exposure to formamidines during 
gestation and lactation induces permanent alterations on 
serotoninergic system in adult age. Chlordimeform was 
chosen because it is the most representative compound 
in its group which presents a very low inhibition of MAO, 
allowing us to study more clearly whether the permanent 
changes observed on levels of serotonin neurotransmit-
ter are due to an alteration of the enzymes that catalyze 
the synthesis and metabolism of these neurotransmitter 
rather than inhibition of MAO.
This work focuses its interest in providing new data of for-
mamidines induced neurotoxicity during nervous system 
development, because new compounds of this family are 
being developed with therapeutic applications for which 
these effects are not considered in their risk assessment, 
which poses a potential health hazard.
Materials and methods 
Biological material 
All experiments were performed in accordance with Eu-
ropean Union guidelines (2003/65/CE) and Spanish re-
gulations (BOE 67/8509-12, 1988) regarding the use of 
laboratory animals. Six pregnant Wistar rats were housed 
individually in polycarbonate cages and were assigned 
randomly to two experimental groups: a chlordimeform 
treatment group (n = 3) and a control group (n = 3).
Test Chemical and Treatment
Chlordimeform (Sigma, Madrid, Spain) was dissolved in 
corn oil to provide fast and complete absorption and was 
administered orally by gavage in a volume of 2 mg/ml. 
The animals received daily chlordimeform at the dose of 
5 mg/kg on days 6 to 21 of pregnancy (GD 6-21) and on 
days 1 to 10 of lactation (PN 1-10). Control dams recei-
ved vehicle (corn oil 2.5 ml/ kg) on the same schedules. 
Dose of chlordimeform was selected based on previous 
preliminary study that indicated this dose was the higher 
one that did not cause weight loss or mortality, any re-
duction of food or water intake as well as did not induce 
haematological modifications of other clinical histopatho-
logical signs of overt toxicity. Moreover we did not see 
any changes in suckling of maternal caretaking. None of 
the prenatal or postnatal treatment evoked a significant 
change in weight of any of the brain regions on PN 60 
(data not shown).
Dams were examined daily throughout the gestation and 
lactation periods for mortality, general appearance and be-
haviour. The maternal body weights were measured on 
GD 1, GD 5, GD 6, GD 15 and GD 20. Food and water 
consumption during pregnancy, length of gestation, litter 
size and sex ratio were also assessed. 
On PN1, all litters were examined externally, sexed and 
weighed. Litters were organized in groups of twelve pups, 
six males and six females. Litters were weighed at PN 1, 
PN 7, PN14 and PN 21. The offspring were weaned on 
lactation day 21 and were maintained in appropriate con-
ditions, housed individually and without any treatment with 
full access to food and water until adult age. The study 
was organized in treated groups of six males and six fema-
les randomly selected respectively from the dams’ litters 
exposed to chlordimeform, and control groups of six ma-
Figure 1: Chlodimeform chemical structure (C10H13Cl N2).
Cl N= CH - N
CH3
CH3
CH3
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les and six females pups randomly selected respectively 
from the control dams’ litters.
At PN 60, male and female rats from control and treated 
groups (pups from control dams, and pups from dams 
exposed to chlordimeform, respectively) were sacrificed 
by decapitation. The brain was removed quickly and the 
hypothalamus, midbrain, medulla oblongata, cerebellum, 
brainstem, hippocampus, striatum and prefrontal cortex 
were rapidly dissected out at 4ºC14. Tissues were rapidly 
weighed and stored at -80 ºC until analysis. All data were 
collected by experimenters blind to the treatment condi-
tion of the offspring.
Determination of monoamine levels
Following sample collections, 300-800 μl of 0.4 M HClO4 
containing 0.1% (w/v) Na2S2O5 was added to the tissues, 
and the mixture was homogenized by sonication before 
neurochemical evaluation was performed. The homoge-
nates were centrifuged for 15 min at 20000 g at 4º C and 
aliquots of supernatants were taken for analysis of seroto-
nin (5-HT) and its metabolite [5-hydroxy-3-indolacetic acid 
(5-HIAA)] using a high performance liquid chromatography 
(HPLC) technique with electrochemical detection 15,13. Vo-
lumes of 200-300 μl of the supernatants (in 0.4 M HClO4) 
were treated for 3 min at 100º C in a water bath. The 
samples were then cooled and 30-45 μl of 2 M NaOH 
were added (final pH: ca. 1.5) and aliquots were injected 
into a reversed phase HPLC system. For the analysis of 
the indolalkylamines 5-HT and 5-HIAA, the mobile phase 
consisted of 0.1 M Na2HPO4. 2H2O, 0.1 M citric acid (pH 
3.5) and 10% (v/v) methanol. Elution was performed at a 
flow rate of 1 ml/min and the working electrode potential 
was set at 0.7 V for indolalkylamines. 
Peak areas in the sample chromatograms were quantita-
ted by external standard technique using solutions of the 
indolalkylamines (5-HT and 5-HIAA). 5-HT turnover was 
calculated as ratio of metabolite to neurotransmitter.
Data analysis
Statistical analysis of data was performed using a Statgra-
phics software, version Plus 4.1 for windows. Values are 
expressed as mean ± S.E.M. obtained from 12 animals, 
six males and six females, in each group (control and trea-
ted groups). For values combined for males and females, 
a two-way ANOVA with treatment × sex interaction was the 
initial test used. Where a significant treatment × sex interac-
tion was detected, a separate Student’s t test was carried 
out for each sex. The results were considered significant at 
P <0.05. Results significantly different from controls are also 
presented as change from control (%).
Results 
Maternal and offspring body weight, physical and ge-
neral activity development were unaffected by the ex-
posure of dams to chlordimeform (5v mg/kg bw orally 
on days 6 to 21 of pregnancy and 1 to 10 of lactation). 
No differences were found between the body weights of 
the control and treated dams throughout the pregnancy 
(data not shown). There were no significant differences 
in the length of gestation as well as in the litter sizes bet-
ween dams receiving chlordimeform and those receiving 
corn oil (control group) (data not shown). Furthermore, 
no pups were found dead at birth and there were no 
differences detected in pup weights immediately after bir-
th. Malformation or other overt signs of pesticide toxicity 
were neither observed. Body weights of pregnant dams 
and their offspring were unaffected by chlordimeform 
exposure. In addition, no differences were found in the 
general maternal behaviour of control and treated dams. 
Differences were not detected in the body weight of male 
and female offspring on days 1, 7, 14, 21 (weaning) and 
at 60 of life (data not shown).
Brain tissues levels of serotonin, its metabolite and the 
turnover in rat pups at PN 60 are presented in Table I. In 
the hypothalamus, midbrain, cerebellum, medulla oblon-
gata and brainstem, 5-HT, 5-HIAA levels and 5-HIAA/5-
HT ratio were not modified by dam exposure to chlordi-
meform in males and females rat pups at PN 60. In male 
and female offspring, chlordimeform induced a signifi-
cant decrease in striatum and prefrontal cortex 5-HT and 
5-HIAA levels and an increase of 5-HT and 5-HIAA levels 
in the hippocampus compared to control animals, displa-
ying in the hippocampus and frontal cortex a significant 
sex interaction with the treatment effect (Tables I and II).
 
In striatum, the reduction of 5-HT content was 15.75% 
(P <0.001) and 20.92% (P <0.001) for 5-HIAA. In frontal 
cortex, the reduction of 5-HT content was a 16.99% (P 
<0.001) and a 31.01% (P <0.001) in males and females 
respectively and the loss in the content of 5-HIAA was a 
31.56% (P <0.001) and a 21.44% (P <0.001) in males 
and females respectively. In hippocampus the increase 
of 5-HT content was a 31.05% (P <0.001) and a 19.77% 
(P <0.001) in males and females respectively, and the in-
crease of 5-HIAA content was a 37.44% (P <0.001) and 
13.49% (P <0.001) in males and females respectively. 
Turnover rate suffered a statistically significant reduction 
of 18.02% (P <0.01) in males’ frontal cortex and 5.08% 
(P <0.001) in females’ hippocampus. However, the tur-
nover rate suffered a significant increase of 4.89% (P 
<0.01) in males’ hippocampus and 13, 92% (P <0.001) 
in females’ frontal cortex (Tables I and II).
Discussion 
The present study shows that prenatal and postnatal ex-
posure to chlordimeform (5 mg/kg bw orally on days 6 
to 21 of pregnancy and 1 to 10 of lactation) was not 
able to induce maternal toxicity since during pregnancy 
maternal weight gain of treated rats was not modified. In 
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addition, the pesticide did not impair offspring weight; the 
weight was similar both in pups from treated dams and 
from control dams. Prenatal and postnatal maternal ex-
posure to chlordimeform did not change the time course 
of male and female offspring growth and general activi-
ty, being these data in agreement with the obtained with 
amitraz treatment13. However, chlordimeform administe-
red during pregnancy and lactation leads to permanent 
alterations of the serotonergic system in a sex and region 
dependent way at 60 days of age in rats. Chlordimeform 
affected the content of 5-HT only in the regions frontal 
cortex, hippocampus and striatum. The effects observed 
in our study included a significant decrease of seroto-
nin and its metabolite levels in striatum and frontal cor-
tex and an increase in hippocampus, displaying only in 
the prefrontal cortex and hippocampus a significant sex 
interaction with the treatment. Moreover, chlordimeform 
evoked an increase in 5-HT turnover in prefrontal cortex 
and hippocampus from females and males respectively 
but evoked a decrease in these regions from males and 
females respectively.
Developmental neurotoxicity involves alterations in beha-
viour, neurohistology, neurochemistry and/or gross dys-
morphology of central nervous system occurring in the 
offspring, as a result of chemical exposure of the mother 
during pregnancy or lactation. The mechanism through 
which these permanent effects on serotoninergic system 
take place is unknown, but monoamine neurotransmit-
ters, such as 5-HT regulate brain development prior to as-
suming their roles as transmitters in the mature brain16-18, 
thus any circumstance that affects these neurotransmit-
ters in the developing brain can alter the final structure 
and function of that brain. Since the endogenous levels 
of serotonin are highly regulated by MAO, any change in 
this enzyme can profoundly affect the developing brain. 
In this sense, it has been reported that gestational expo-
sure to MAO inhibitors clorgyline and deprenyl produce 
in offspring at 30 days of age, a significant reduction of 
serotonergic innervation particularly in the cerebral cor-
tex19. Moreover, amitraz, which is a potent MAO inhibi-
tor2, has been shown to induce permanent alterations 
of monominergic neurotransmitters systems13 similar to 
those induced by chlordimeform through gestational and 
lactational exposure. Because chlordimeform is a very 
week inhibitor of MAO, this mechanism could not sup-
port the alterations in serotonergic system observed in 
the present study, and thus in formamidine pesticides, 
suggesting other mechanisms are implicated. 
On the other hand, it has been also described that ste-
roids play a role in the development of catecholamines 
systems20-23, and may play a critical role in mammalian 
brain developmental of both sexes24. In this sense chlor-
dimeform has been reported to disruptor different steroi-
ds hormones7, which could also contribute to the perma-
nent effects observed. Moreover, chlordimeform could 
also affect the neuronal cell replication, differentiation, 
synaptogenesis and axonogenesis, steroid metabolism, 
and functional development of neurotransmitter systems, 
effects that could result in behavioural alterations obser-
ved in previous studies after developmental exposure to 
chlordimeform25. The loss of serotoninergic projections 
could also play an important role in the behavioural alte-
rations. Prenatal exposure to chlordimeform may result 
in either direct damage or enhanced vulnerability of the 
neurotransmitter systems to future toxic insult. 
Given that the serotoninergic system alteration in the 
brain regions of our study with chlodimeform (frontal cor-
tex, striatum, and hippocampus) was the same as those 
affected by amitraz13 it can be inferred that the mecha-
HT: hypothalamus; MB: midbrain; CB: cerebellum; MO: medulla oblongata; BS: brainstem; PFC: prefrontal cortex; 
ST: striatum; HC: hippocampus. 
Data represent means ± S.E.M. with values for males and females combined (n=12: 6 males + 6 females). 
Statistical significance is reported for the *P<0.05, **P<0.01 and ***P<0.001 levels compared with the control group.
a Percentage change from control values.
b Significant treatment × sex interaction.
Table I: Tissue 5-HT and 5-HIAA concentrations in male and female rat pups observed at 60 days of age after the exposure of dams to chlordimeform (5 mg/kg bw 
orally on days 6 to 21 of pregnancy and 1 to 10 of lactation).
 5-HT (ng/g) 5-HIAA (ng/g) 5-HIAA/5-HT
 Control Treated group Control Treated group Control Treated group
 group (pups from group (pups from group (pups from
  treated dams)  treated dams)  treated dams)
HT 2211,69 ± 39,58 2246,49 ± 43,96 1175,98 ± 39,15 1210,17± 43,53 0,53 ± 0,02 0,54 ± 0,03
MB 2605,67 ± 23,42 2619,96 ± 22,86 1721,96 ± 11,30 1725,23 ±13,72 0,66 ± 0,01 0,66 ± 0,01
CB 131,96 ± 7,43 136,73 ± 7,52 116,42 ± 4,06 120,80 ± 5,12 0,90 ± 0,06 0,90 ± 0,08
MO 1204,19 ± 28,25 1206,92 ± 43,62 838,13 ± 17,51 845,56 ± 17,22 0,70 ± 0,02 0,71 ± 0,03
BS 858,80 ± 14,96 869,82 ± 19,58 452,34 ± 9,25 456,68 ± 15,93 0,53 ± 0,01 0,53 ± 0,03
PFC 1172,90 ± 26,90 b890,30 ± 30,44 644,05 ± 15,48 b471,59 ± 6,84 0,55 ± 0,02 b0,53 ± 0,02
ST 848,38 ± 4,72 714,77 ± 5,54***,   726,27 ± 8,55 574,37 ± 26,03***,  0,86 ± 0,01 0,80 ± 0,04
  a(-15,75)  a(-20,92)
HC 534,01 ± 4,45 b669,83 ± 16,23 474,60 ± 6,82 b594,50 ± 20,10 0,89 ± 0,01 b0,89 ± 0,02 
Tissue
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nism by which formamidines alter CNS development is 
similar. Moreover, these brain regions participate in the 
regulation of learning and memory processes26-31, thus, 
it could be considered that these processes could be 
compromised by exposure during gestation and lactation 
to formamidines. In addition, the dysfunction in serotonin 
system is involved in appetite, affective, neuropsychiatric 
disorders32-35, among others, which could be also indu-
ced by formamidine exposure during development. Fur-
ther studies are needed to test these functions to confirm 
that alteration of this neurotransmitter system is the cause 
of some of these dysfunctions. 
Conclusion 
The results of this investigation show that formamidines, 
particularly the chlordimeform, cause developmental 
neurotoxicity at serotonergic system level. Further stu-
dies are required to determine the possible mechanisms 
through which formamidines induced these effects, spe-
cifically the hormonal disruption effects. It is also nee-
ded a pathologic examination in the affected regions to 
determine the effect on the number of neurons, to de-
termine if there is a reduction in innervation. Currently, 
new molecules with therapeutic application are being 
developed as the N-hydroxy-N-(4-butyl-2-methylphenyl) 
formamidine (HET0016) with protective effects against 
cardiovascular and cerebrovascular diseases. Until now 
the risk assessment of the family of these compounds 
has been taken from the standpoint of carcinogenesis. In 
view of these results it might be appropriate to reconsider 
the risk assessment of the members of this family based 
not only on their possible carcinogenic effects but also 
in the neurotoxic effects during development.The results 
reported in this study are of great importance and should 
be incorporated into the risk assessment of pesticides 
formamidines group.
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PFC: prefrontal cortex. Other tissue values were not evaluated because of the lack of treatment × sex interactions.
Values are mean ± S.E.M.; control animals (n= 6 males, n= 6 females); treated group (n= 6 males, n= 6 females).
Statistical significance is reported for the **P<0.01 and ***P<0.001 levels compared with the control group within each sex as determined by one-way ANOVA, 
followed by the Student´s t test.
a Percentage change from control values.
Table II: Statistical analysis for tissue values with significant treatment × sex interaction
 5-HT (ng/g) 5-HIAA (ng/g) 5-HIAA/5-HT
 Control Treated group Control Treated group Control Treated group
 group (pups from group (pups from group (pups from
  treated dams)  treated dams)  treated dams)
 1157,41 960,77 ± 2,78***, 679,37 464,96± 8,78***, 0,59 0,4 8± 0,010**, 
 ± 38,5 a(-16,99%) ± 4,49 a(-31,56%) ± 0,021  a(-18,02%) 
 1188,40 819,82 ± 6,68***,  608,73 478,23 ± 2,84***, 0,51     0,58 ± 0,007***,
 ± 8,72 a(-31,01%) ± 6,96 a(-21,44%) ± 0,01 a(13,92%)
 536,10 702,58 ± 5,21***, 466,56 641,25 ± 3,01***, 0,87 0,91 ± 0,010**,
 ± 4,09 a(31,05%) ± 3,45 a(37,44%) ± 0,008 a(4,89%)
 531,91 637,09 ± 11,10***, 482,64   547,74 ± 2,39***, 0,91 0,86 ± 0,017***,
 ± 5,00 a(19,77%) ± 8,04 a(13,49%) ± 0,011 a(-5,08%)
Tissue
Males
CF
HC
Males
Females
Females
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